DataMeds AI, Inc. (MEDS): Long-Term Debt

Annual figures by period end, from SEC filings.

$23.49M

As of 2025-12-31

$31.81M

As of 2026-06-30

2024-12-31 Long-Term Debt (USD) 2025-12-31

Period ended	Long-Term Debt	Change YoY	Source filing
2025-12-31	$23.49M	+0.4%	2026-03-20, Balance as of period end
2024-12-31	$23.38M	n/a	2026-03-20, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Long-Term Debt	Change YoY
DataMeds AI, Inc. (MEDS)	2025-12-31	$23.49M	+0.4%
Cosmos Health Inc. (COSM)	2025-12-31	$3.78M	-8.1%
Stemtech Corp (STEK)	2025-12-31	$4.16M	+9.1%
Herbalife Ltd. (HLF)	2025-12-31	$1.99B	-11.8%
Cencora, Inc. (COR)	2025-09-30	$7.66B	+74.6%
McKesson Corp (MCK)	2026-03-31	$6.53B	+15.4%

Compare MEDS, COSM, STEK, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗